Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04003350 · ClinicalTrials.gov registry record · NA

The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

A NA study, sponsored by Rothman Institute Orthopaedics.

Completed
Registry status
NA
Development phase
216
Enrollment target

NCT04003350 is a NA study that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 216 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04003350, a NA study, has completed, sponsored by Rothman Institute Orthopaedics.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target

Study Summary

It is well recognized that a multimodal analgesia program targeting multiple pain pathways, is more effective for controlling pain during the hospital stay and in the acute postoperative period than monotherapy-based regimens, such as opioids only. This multimodal analgesic regimen also leads to reduce opioid consumption and its related side effects after hip and knee joint replacement procedures. One potential strategy to reduce the use of opioids after TKA is to administer a prolonged oral multimodal pain regimen that targets multiple pain pathways in the post hospital discharge period. This can be equal or more effective than the regimen of opioid prescriptions used after TKA. To the best of our knowledge, there have been no studies conducted that directly examine the effect of prolonged multimodal pain regimen after hospital discharge in primary TKA patients. PURPOSE: 1. To determine whether a prolonged multimodal pain regimen after discharge from primary TKA can provide equivalent or better pain control while reducing opioid consumption and, subsequently, opioid-related side effects. 2. To determine whether patient expectations and routine opioid prescription practices at the time of discharge from primary TKA impacts opioid consumption.

Interventions

  • DRUG Tylenol
  • DRUG Oxycodone
  • DRUG Gabapentin
  • DRUG Tramadol
  • DRUG Meloxicam

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2017-12-21
Est. Completion 2019-03-15
Phase NA

Sponsor

Rothman Institute Orthopaedics

23 total trials

What the Registry Record Tells You About NCT04003350

The ClinicalTrials.gov registry entry for NCT04003350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rothman Institute Orthopaedics, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Tylenol is the first listed.

NCT04003350 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04003350 about?

NCT04003350 is a clinical study titled "The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty". It is well recognized that a multimodal analgesia program targeting multiple pain pathways, is more effective for controlling pain during the hospital stay and in the acute postoperative period than monotherapy-based regimens, such as opioids only. This multimodal analgesic regimen also leads to red...

What is the current status of trial NCT04003350?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2017-12-21. Estimated completion is 2019-03-15.

What interventions are being tested in trial NCT04003350?

The interventions under investigation include: Tylenol (DRUG), Oxycodone (DRUG), Gabapentin (DRUG), Tramadol (DRUG), Meloxicam (DRUG).

Who is sponsoring clinical trial NCT04003350?

This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.